X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (408) 408
Publication (26) 26
Newsletter (13) 13
Book Review (6) 6
Transcript (4) 4
Newspaper Article (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
icatibant (385) 385
bradykinin (197) 197
humans (165) 165
index medicus (164) 164
hereditary angioedema (139) 139
bradykinin - analogs & derivatives (126) 126
immunology (100) 100
angioedema (92) 92
male (86) 86
angioneurotic edema (84) 84
allergy (81) 81
animals (80) 80
female (79) 79
pharmacology & pharmacy (79) 79
bradykinin - therapeutic use (67) 67
receptor antagonist (57) 57
bradykinin - pharmacology (55) 55
management (55) 55
angioedemas, hereditary - drug therapy (53) 53
ecallantide (53) 53
edema (51) 51
adult (44) 44
middle aged (41) 41
diagnosis (37) 37
research (37) 37
care and treatment (36) 36
bradykinin receptor antagonists (35) 35
c1 inhibitor (35) 35
treatment outcome (35) 35
acute attacks (34) 34
angioedema - drug therapy (34) 34
attacks (33) 33
c1 inhibitor deficiency (33) 33
rats (32) 32
bradykinin - administration & dosage (31) 31
patients (31) 31
hoe-140 (30) 30
c1 inhibitor concentrate (29) 29
aged (28) 28
bradykinin - metabolism (28) 28
complement c1 inhibitor protein - therapeutic use (28) 28
concentrate (26) 26
deficiency (26) 26
drug therapy (26) 26
c1-inhibitor (25) 25
angiotensin-converting enzyme inhibitors - adverse effects (24) 24
potent (24) 24
angioedemas, hereditary - diagnosis (23) 23
angiotensin (23) 23
medicine, general & internal (23) 23
prophylaxis (23) 23
allergy and immunology (22) 22
bradykinin b2 receptor antagonists (22) 22
bradykinin b2 receptor antagonists - therapeutic use (22) 22
angioedema - diagnosis (21) 21
antagonist icatibant (21) 21
dermatology (21) 21
ace inhibitors (20) 20
c1 esterase inhibitor (20) 20
plasma (20) 20
therapy (20) 20
angioedema - chemically induced (19) 19
c1-inhibitor concentrate (19) 19
efficacy (19) 19
internal medicine (19) 19
kallikrein (19) 19
analysis (18) 18
angioedema - therapy (18) 18
c1-inh (18) 18
enzymes (18) 18
fresh-frozen plasma (18) 18
health aspects (18) 18
kinins (18) 18
medicine & public health (18) 18
tranexamic acid (18) 18
angioedema - etiology (17) 17
antagonist (17) 17
asthma (17) 17
c1-inhibitor deficiency (17) 17
dose-response relationship, drug (17) 17
bradykinin - adverse effects (16) 16
mice (16) 16
rats, sprague-dawley (16) 16
ace inhibitor (15) 15
acquired angioedema (15) 15
angiotensin-converting enzyme inhibitors (15) 15
inflammation (15) 15
symptoms (15) 15
young adult (15) 15
angioneurotic-edema (14) 14
angiotensin-converting enzyme inhibitors - pharmacology (14) 14
anti-inflammatory agents, non-steroidal - therapeutic use (14) 14
biochemistry & molecular biology (14) 14
complement c1 inhibitor protein (14) 14
histamine (14) 14
mutation (14) 14
pain (14) 14
receptor (14) 14
receptor, bradykinin b2 (14) 14
receptor, bradykinin b2 - metabolism (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (384) 384
German (25) 25
French (11) 11
Spanish (5) 5
Polish (1) 1
Portuguese (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


R & D Focus Drug News, ISSN 1350-1135, 04/2020
Journal Article
Allergy, Asthma and Clinical Immunology, ISSN 1710-1484, 08/2018, Volume 14, Issue 1, pp. 28 - 11
Background: Hereditary angioedema (HAE) is a potentially life-threatening, bradykinin-mediated disease, often misdiagnosed and under-treated, with long... 
Acquired angioedema | Hereditary angioedema | Icatibant Outcome Survey | Icatibant | C1-inhibitor deficiency | ATTACKS | MANAGEMENT | CONSENSUS | ILLNESS | IMMUNOLOGY | C1 INHIBITOR DEFICIENCY | HUMANISTIC BURDEN | ALLERGY | QUALITY-OF-LIFE | REGISTRY | Angioneurotic edema | Usage | Care and treatment | Gene mutations | Bradykinin | Analysis | Diagnosis | Research | Patients | Illnesses | Clinical medicine | Quality of life | Asthma
Journal Article
Allergy, ISSN 0105-4538, 11/2011, Volume 66, Issue 11, pp. 1397 - 1406
Journal Article
Journal of Clinical Neuroscience, ISSN 0967-5868, 03/2018, Volume 49, pp. 38 - 39
•Orolingual angioedema is a rare side effect of thrombolysis.•Angioedema is uniquely observed as being ipsilateral to the weakness.•Icatibant, a bradykinin... 
Stroke | Icatibant | Ischaemic | Angioedema | Bradykinin | NEUROSCIENCES | CLINICAL NEUROLOGY
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 2016, Volume 117, Issue 3, pp. 321 - 322
Journal Article
Clinical & Experimental Allergy, ISSN 0954-7894, 01/2017, Volume 47, Issue 1, pp. 139 - 140
Journal Article
Allergy, ISSN 0105-4538, 06/2017, Volume 72, Issue 6, pp. 994 - 998
Journal Article
Israel Medical Association Journal, ISSN 1565-1088, 04/2018, Volume 20, Issue 4, pp. 227 - 232
Background: Management of patients with hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is evolving worldwide. Evaluating the Israeli... 
Hereditary angioedema | Icatibant Outcome Survey (IOS) | Israel | C1-inhibitor deficiency (C1-INH-HAE) | IOS | Icatibant | ATTACKS | DIAGNOSIS | MANAGEMENT | OPEN-LABEL | icatibant | RECEPTOR ANTAGONIST | INTERNATIONAL WORKING GROUP | CONSENSUS REPORT | C1 INHIBITOR | hereditary angioedema | MEDICINE, GENERAL & INTERNAL | INHIBITOR DEFICIENCY | REPEAT TREATMENT
Journal Article
Allergy, ISSN 0105-4538, 11/2013, Volume 68, Issue 11, pp. 1452 - 1459
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 01/2019, Volume 33, Issue 1, pp. 163 - 169
Background The Icatibant Outcome Survey (IOS; NCT01034969) is a Shire‐sponsored, international, observational study monitoring the safety and effectiveness of... 
VALIDATION | ATTACKS | SYMPTOMS | DISEASE | DERMATOLOGY | Original | Autoimmune Diseases
Journal Article
CLINICAL AND TRANSLATIONAL ALLERGY, ISSN 2045-7022, 07/2019, Volume 9, Issue 1, pp. 37 - 8
Background: Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is characterized by recurrent swelling in subcutaneous or submucosal tissues.... 
Hereditary angioedema | Icatibant Outcome Survey | ALLERGY | UPDATE | Safety | Elderly | BURDEN | RECEPTOR ANTAGONIST | Drugs | Medical research | Angioneurotic edema | Comorbidity | Patient outcomes | Medicine, Experimental | Aged patients | Icatibant | Life Sciences | Human health and pathology | Immunology
Journal Article
International Archives of Allergy and Immunology, ISSN 1018-2438, 07/2015, Volume 167, Issue 1, pp. 21 - 28
Journal Article